Bank Of New York Mellon Corp Acelrx Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$1.03 - $1.7 $196,479 - $324,286	-190,757 Reduced 84.8%	34,182 $47,000
Q1 2021 May 13, 2021	SELL	$1.25 - $2.77 $14,146 - $31,348	-11,317 Reduced 4.79%	224,939 $382,000
Q4 2020 Feb 09, 2021	SELL	$1.18 - $1.98 $8,453 - $14,184	-7,164 Reduced 2.94%	236,256 $292,000
Q3 2020 Nov 12, 2020	SELL	$1.01 - $1.81 $3,706 - $6,642	-3,670 Reduced 1.49%	243,420 $345,000
Q2 2020 Aug 12, 2020	BUY	$1.03 - $1.69 $14,939 - $24,511	14,504 Added 6.24%	247,090 $298,000
Q1 2020 May 06, 2020	SELL	$0.76 - $2.07 $8,937 - $24,343	-11,760 Reduced 4.81%	232,586 $274,000
Q3 2019 Nov 07, 2019	SELL	$2.1 - $2.87 $20,218 - $27,632	-9,628 Reduced 3.79%	244,346 $537,000
Q2 2019 Aug 12, 2019	BUY	$2.1 - $3.93 $402,007 - $752,327	191,432 Added 306.09%	253,974 $643,000
Q1 2019 May 14, 2019	SELL	$2.35 - $3.83 $10,826 - $17,644	-4,607 Reduced 6.86%	62,542 $218,000
Q4 2018 Feb 11, 2019	BUY	$2.13 - $4.8 $50,834 - $114,556	23,866 Added 55.14%	67,149 $155,000
Q3 2018 Nov 09, 2018	SELL	$2.6 - $4.6 $1,872 - $3,311	-720 Reduced 1.64%	43,283 $0
Q2 2018 Aug 06, 2018	SELL	$2.13 - $4.2 $30,373 - $59,892	-14,260 Reduced 24.48%	44,003 $149,000
Q1 2018 May 15, 2018	BUY	$1.7 - $2.35 $6,687 - $9,244	3,934 Added 7.24%	58,263 $122,000
Q4 2017 Feb 09, 2018	BUY	$1.75 - $5.5 $95,075 - $298,809	54,329	54,329 $110,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.